1. Home
  2. MAXN vs LITS Comparison

MAXN vs LITS Comparison

Compare MAXN & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maxeon Solar Technologies Ltd.

MAXN

Maxeon Solar Technologies Ltd.

HOLD

Current Price

$1.76

Market Cap

40.6M

Sector

Technology

ML Signal

HOLD

LITS

Lite Strategy Inc.

N/A

Current Price

$1.19

Market Cap

40.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MAXN
LITS
Founded
2019
2000
Country
Singapore
United States
Employees
N/A
4
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.6M
40.8M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
MAXN
LITS
Price
$1.76
$1.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
89.8K
292.3K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$100.37
N/A
Revenue Next Year
$24.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.95
$0.95
52 Week High
$4.97
$3.03

Technical Indicators

Market Signals
Indicator
MAXN
LITS
Relative Strength Index (RSI) 27.57 52.44
Support Level N/A $1.17
Resistance Level $3.78 $1.27
Average True Range (ATR) 0.19 0.06
MACD -0.03 0.01
Stochastic Oscillator 30.53 61.11

Price Performance

Historical Comparison
MAXN
LITS

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, Italy, and Rest of world.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Share on Social Networks: